Mark J. Vignola, Chief Financial Officer at Terns Pharmaceuticals, Inc. (TERN), bought 3 shares at $1.41 ($4) on 2022-11-30, disclosed to the SEC on 2023-02-03.
Open-market purchase of $4 TERN by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| TERN | BUY | 2024-06-04 | $21K | — | Filing → |
| TERN | BUY | 2023-12-04 | $3K | — | Filing → |
| TERN | BUY | 2023-06-02 | $14K | — | Filing → |